UnknownNot Applicable

Liver Transplantation for Unresectable GIST Liver Metastases

Spain50 participantsStarted 2022-05

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * GIST diagnosis (c-Kit, CD34, DOG-1) * Imatinib-sensitive mutation * Non-resectable liver metastases * Abscence of extrahepatic disease * Period greater than two years between primary tumor and metastases diagnosis

What they're measuring

Overall Survival

Timeframe: Through study completion, an average of 2 years

Graft Survival

Timeframe: Through study completion, an average of 2 years

Trial details

NCT IDNCT04825470

SponsorHospital Universitario Virgen de la Arrixaca

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12

View on ClinicalTrials.gov More Liver Diseases trials